Variant report

Variant	esv3345863
Chromosome Location	chr7:3339851-3342399
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:542)
CpG islands
(count:611)
Chromatin interactive
region (count:5)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:542 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr7:3340510-3340769	HepG2	liver:	n/a	n/a
2	ARID3A	chr7:3340556-3340788	K562	blood:	n/a	n/a
3	BACH1	chr7:3341623-3341680	H1-hESC	embryonic stem cell:	n/a	n/a
4	BACH1	chr7:3339959-3340991	H1-hESC	embryonic stem cell:	n/a	n/a
5	BCLAF1	chr7:3340395-3340873	GM12878	blood:	n/a	chr7:3340634-3340647 chr7:3340524-3340537 chr7:3340744-3340757
6	BCLAF1	chr7:3340441-3340719	GM12878	blood:	n/a	chr7:3340634-3340647 chr7:3340524-3340537
7	BHLHE40	chr7:3340409-3341002	HepG2	liver:	n/a	chr7:3340932-3340948 chr7:3340519-3340535 chr7:3340527-3340543
8	BHLHE40	chr7:3340404-3341008	K562	blood:	n/a	chr7:3340932-3340948 chr7:3340519-3340535 chr7:3340527-3340543
9	BHLHE40	chr7:3340387-3340937	GM12878	blood:	n/a	chr7:3340519-3340535 chr7:3340527-3340543
10	BRCA1	chr7:3340563-3340738	HepG2	liver:	n/a	n/a
11	CBX3	chr7:3340439-3340719	K562	blood:	n/a	n/a
12	CBX3	chr7:3340484-3340710	K562	blood:	n/a	n/a
13	CBX3	chr7:3340323-3340885	HCT-116	colon:	n/a	n/a
14	CCNT2	chr7:3340411-3341005	K562	blood:	n/a	n/a
15	CHD1	chr7:3340292-3340917	IMR90	lung:	n/a	n/a
16	CHD2	chr7:3340488-3340695	H1-hESC	embryonic stem cell:	n/a	n/a
17	CHD2	chr7:3340511-3340673	HepG2	liver:	n/a	n/a
18	CHD2	chr7:3340606-3340636	K562	blood:	n/a	n/a
19	CHD2	chr7:3340519-3340719	GM12878	blood:	n/a	n/a
20	CREB1	chr7:3340132-3341053	A549	lung:	n/a	n/a
21	CREB1	chr7:3340365-3341037	HepG2	liver:	n/a	n/a
22	CTBP2	chr7:3340345-3341019	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr7:3342020-3342170	HepG2	liver:	n/a	n/a
24	CTCF	chr7:3341860-3342010	SAEC	small airway:	n/a	n/a
25	CTCF	chr7:3340280-3340430	AG04450	lung:	n/a	n/a
26	CTCF	chr7:3340240-3340450	AG09319	gingival:	n/a	n/a
27	CTCF	chr7:3342020-3342170	AG04450	lung:	n/a	n/a
28	CTCF	chr7:3342040-3342190	Hela-S3	cervix:	n/a	n/a
29	CTCF	chr7:3342100-3342250	GM12871	blood:	n/a	n/a
30	CTCF	chr7:3340503-3340768	SK-N-SH_RA	brain:	n/a	n/a
31	CTCF	chr7:3340540-3340690	MCF-7	breast:	n/a	n/a
32	CTCF	chr7:3342120-3342270	NHLF	lung:	n/a	n/a
33	CTCF	chr7:3340855-3340885	GM20000	blood:	n/a	n/a
34	CTCF	chr7:3340540-3340690	HCM	heart:	n/a	n/a
35	CTCF	chr7:3342089-3342176	LNCaP	prostate:	n/a	n/a
36	CTCF	chr7:3342060-3342210	HCPEpiC	choroid plexus:	n/a	n/a
37	CTCF	chr7:3342020-3342170	HCPEpiC	choroid plexus:	n/a	n/a
38	CTCF	chr7:3340540-3340690	WERI-Rb-1	eye:	n/a	n/a
39	CTCF	chr7:3342040-3342190	RPTEC	kidney:	n/a	n/a
40	CTCF	chr7:3340520-3340670	HEK293	kidney:	n/a	n/a
41	CTCF	chr7:3342060-3342210	HBMEC	blood vessel:	n/a	n/a
42	CTCF	chr7:3340540-3340690	GM12866	blood:	n/a	n/a
43	CTCF	chr7:3340485-3340757	GM20000	blood:	n/a	n/a
44	CTCF	chr7:3340540-3340690	NHLF	lung:	n/a	n/a
45	CTCF	chr7:3342020-3342170	NHDF-neo	bronchial:	n/a	n/a
46	CTCF	chr7:3340505-3340752	LNCaP	prostate:	n/a	n/a
47	CTCF	chr7:3341980-3342130	HFF-Myc	foreskin:	n/a	n/a
48	CTCF	chr7:3340456-3340765	Gliobla	brain:	n/a	chr7:3340483-3340496
49	CTCF	chr7:3342020-3342170	SK-N-SH_RA	brain:	n/a	n/a
50	CTCF	chr7:3340470-3340763	MCF-7	breast:	n/a	chr7:3340483-3340496

(count:611 , 50 per page) page: 1 2 3 4 5 6 7 ... 13

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr7:3341875-3341925	ovcar-3	ovarian:	n/a
2	chr7:3341875-3341925	ovcar-3	ovarian:	n/a
3	chr7:3342048-3342098	NT2-D1	testis:	n/a
4	chr7:3340860-3340910	PrEC	prostate:	n/a
5	chr7:3341630-3341680	GM19239	blood:	n/a
6	chr7:3341934-3341984	HAEpiC	amniotic membrane:	n/a
7	chr7:3341630-3341680	Hepatocyte	liver:	n/a
8	chr7:3341875-3341925	NB4	blood:	n/a
9	chr7:3341694-3341744	K562	blood:	n/a
10	chr7:3342048-3342098	HEEpiC	esophagus:	n/a
11	chr7:3340979-3341029	HRCEpiC	kidney:	n/a
12	chr7:3340459-3340509	Caco-2	colon:	n/a
13	chr7:3340459-3340509	NB4	blood:	n/a
14	chr7:3342048-3342098	PFSK-1	brain:	n/a
15	chr7:3341524-3341574	HAEpiC	amniotic membrane:	n/a
16	chr7:3341630-3341680	SKMC	muscle:	n/a
17	chr7:3340866-3340916	SK-N-SH_RA	brain:	n/a
18	chr7:3341934-3341984	HEK293	kidney:	embryo
19	chr7:3341875-3341925	NT2-D1	testis:	n/a
20	chr7:3342048-3342098	HepG2	liver:	n/a
21	chr7:3340866-3340916	HMEC	breast:	n/a
22	chr7:3341630-3341680	ProgFib	skin:	n/a
23	chr7:3341694-3341744	NHBE	bronchial:	n/a
24	chr7:3340866-3340916	CMK	blood:	n/a
25	chr7:3340979-3341029	A549	lung:	n/a
26	chr7:3341630-3341680	HIPEpiC	eye:	n/a
27	chr7:3340866-3340916	PrEC	prostate:	n/a
28	chr7:3340459-3340509	GM12892	blood:	n/a
29	chr7:3341875-3341925	AG04449	skin:	fetal
30	chr7:3340459-3340509	K562	blood:	n/a
31	chr7:3341630-3341680	ECC-1	luminal epithelium:	n/a
32	chr7:3341630-3341680	HRE	kidney:	n/a
33	chr7:3340459-3340509	U87	brain:	n/a
34	chr7:3342048-3342098	HIPEpiC	eye:	n/a
35	chr7:3340866-3340916	K562	blood:	n/a
36	chr7:3341694-3341744	AG04450	lung:	fetal
37	chr7:3340459-3340509	SAEC	small airway:	n/a
38	chr7:3341524-3341574	ovcar-3	ovarian:	n/a
39	chr7:3341524-3341574	Caco-2	colon:	n/a
40	chr7:3340979-3341029	HCM	heart:	n/a
41	chr7:3341875-3341925	IMR90	lung:	fetal
42	chr7:3340866-3340916	HEEpiC	esophagus:	n/a
43	chr7:3340860-3340910	NHBE	bronchial:	n/a
44	chr7:3341630-3341680	BJ	skin:	n/a
45	chr7:3340459-3340509	SKMC	muscle:	n/a
46	chr7:3341875-3341925	Hepatocyte	liver:	n/a
47	chr7:3340866-3340916	NB4	blood:	n/a
48	chr7:3341524-3341574	RPTEC	kidney:	n/a
49	chr7:3340459-3340509	BE2_C	brain:	n/a
50	chr7:3340459-3340509	HCT-116	colon:	n/a

(count:5 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr7:3194510..3195232-chr7:3340158..3340723,2	MCF-7	breast:
2	chr7:3254030..3256348-chr7:3338235..3340171,2	MCF-7	breast:
3	chr7:3340063..3340822-chr7:3439252..3440083,5	MCF-7	breast:
4	chr7:3339718..3341766-chr7:3458306..3459954,2	K562	blood:
5	chr7:3250247..3250807-chr7:3340190..3341077,3	MCF-7	breast:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-AC091801.1.1-6	chr7:3341861-3342084	ENSG00000236708.1

No data

Variant related genes	Relation type
ENSG00000236708	TF binding region
SDK1	TF binding region
ENSG00000236708	CpG island
SDK1	CpG island
ENSG00000211544	chromatin interactions

Extended variants
information (count: 123 )
Associated
traits (count: 81 )

Variant overlapped rSNPs/rCNVs (count:123 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs574887910	chr7:3339866-3339867	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs62437660	chr7:3339875-3339876	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
3	rs62437661	chr7:3339910-3339911	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
4	rs577495871	chr7:3339953-3339954	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs546105815	chr7:3339954-3339955	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs528248355	chr7:3339964-3339965	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs72576957	chr7:3339978-3339979	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
8	rs572894974	chr7:3339981-3339982	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs192688155	chr7:3339994-3339995	Bivalent/Poised TSS Enhancers Flanking Bivalent TSS/Enh Flanking Active TSS Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
10	rs561302891	chr7:3340000-3340001	Bivalent/Poised TSS Enhancers Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS Bivalent Enhancer Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs530447666	chr7:3340002-3340003	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs550427745	chr7:3340005-3340006	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs62437662	chr7:3340021-3340022	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs566712820	chr7:3340051-3340052	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs184531030	chr7:3340068-3340069	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
16	rs62437663	chr7:3340079-3340080	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
17	rs189274323	chr7:3340085-3340086	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
18	rs528529774	chr7:3340104-3340105	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
19	rs536394241	chr7:3340148-3340149	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
20	rs10261250	chr7:3340187-3340188	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
21	rs537474556	chr7:3340199-3340200	Bivalent/Poised TSS Flanking Active TSS Flanking Bivalent TSS/Enh Enhancers Active TSS Bivalent Enhancer	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
22	rs557663122	chr7:3340217-3340218	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
23	rs62437664	chr7:3340248-3340249	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
24	rs540011481	chr7:3340266-3340267	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
25	rs553254368	chr7:3340354-3340355	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
26	rs573391340	chr7:3340356-3340357	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
27	rs541534226	chr7:3340397-3340398	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
28	rs555059571	chr7:3340400-3340401	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Bivalent Enhancer Enhancers Weak transcription	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
29	rs574880397	chr7:3340428-3340429	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
30	rs543834090	chr7:3340460-3340461	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
31	rs564037149	chr7:3340464-3340465	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
32	rs533036572	chr7:3340487-3340488	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
33	rs115231328	chr7:3340531-3340532	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
34	rs371998776	chr7:3340555-3340556	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
35	rs560060833	chr7:3340560-3340561	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
36	rs181946163	chr7:3340576-3340577	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
37	rs114377917	chr7:3340577-3340578	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
38	rs530921861	chr7:3340586-3340587	Bivalent/Poised TSS Active TSS Flanking Active TSS Bivalent Enhancer Flanking Bivalent TSS/Enh Weak transcription Enhancers	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
39	rs551033491	chr7:3340602-3340603	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
40	rs570836666	chr7:3340612-3340613	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
41	rs539700909	chr7:3340622-3340623	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
42	rs112028917	chr7:3340683-3340684	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
43	rs553653413	chr7:3340712-3340713	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
44	rs566920122	chr7:3340757-3340758	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
45	rs375266803	chr7:3340776-3340777	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
46	rs147487727	chr7:3340795-3340796	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
47	rs555023745	chr7:3340838-3340839	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
48	rs12671946	chr7:3340840-3340841	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
49	rs543795656	chr7:3340853-3340854	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
50	rs184390056	chr7:3340866-3340867	Weak transcription Active TSS Bivalent/Poised TSS	TF binding region CpG island Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:81)

Disease	PMID	Source
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Chordoma	21602918	CNVD
Lynch syndrome	22585707	CNVD
Follicular lymphoma	20505157	CNVD
Breast cancer	16397240	CNVD
Raine Syndrome	17924334	CNVD
Diffuse large b-cell lymphoma	21266526	CNVD
Melanoma	18172304	CNVD
Sudden cardiac death	19188705	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
Prostate cancer	16573809	CNVD
Glioma	18556773	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Ovarian cancer	22174824	CNVD
Urothelial carcinoma	18382360	CNVD
Medulloblastoma	21979893	CNVD
Lynch syndrome	18415027	CNVD
Biliary cancer	19435499	CNVD
Cancer	16751803	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Wilms tumour	21544195	CNVD
Glioblastoma multiforme	17387387	CNVD
Astrocytoma	17387387	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Neuroblastoma	18923191	CNVD
Glioma	21971842	CNVD
Glioblastoma multiforme	21080181	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Oral cancer	21386901	CNVD
colon cancer	17210682	CNVD
Lung adenocarcinoma	21810691	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Colorectal cancer	19359472	CNVD
Hypothalamic hamartomas	18252217	CNVD
Human rectal carcinomas	16397240	CNVD
Peripheral t-cell lymphoma	19118030	CNVD
Medulloblastoma	18056178	CNVD
Basal cell lymphoma	17170743	CNVD
Ewing''s sarcoma	21437220	CNVD
Thyroid cancer	19087340	CNVD
Seminomas	18059402	CNVD
Testicular cancer	18059402	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Autism	19415332	CNVD
Pleomorphic xanthoastrocytoma	20730472	CNVD
T-cell lymphomas	19863542	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
head and neck squamous cell carcinoma	19289630	CNVD
Stenocardia	21860640	CNVD
Vasospasm	21860640	CNVD
Developmental delay	21147756	CNVD
Prostate cancer	18632612	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Ewing''s sarcoma	17952124	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Breast cancer	21364760	CNVD
Nasopharyngeal cancer	20548289	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
small cell lung cancer	20016488	CNVD
Leukemia	23979775	CNVD
Spondylocostal dysostosis	21085971	CNVD
Mental retardation	17901693	CNVD
Heart disease	21282601	CNVD
Glioblastoma multiforme	22286061	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	17053054	CNVD
Cancer	20164920	CNVD
Pancreatic cancer	17952125	CNVD
Colorectal cancer	21645411	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:482 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr7:3335000-3340000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr7:3338600-3340200	Enhancers	NHDF-Ad	bronchial
3	chr7:3339200-3340000	Bivalent Enhancer	Fetal Muscle Trunk	muscle
4	chr7:3339400-3340000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
5	chr7:3339400-3340000	Bivalent Enhancer	Duodenum Mucosa	Duodenum
6	chr7:3339400-3340200	Bivalent Enhancer	Primary T cells fromperipheralblood	blood
7	chr7:3339400-3340200	Bivalent Enhancer	Primary Natural Killer cells fromperipheralblood	blood
8	chr7:3339400-3340200	Flanking Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
9	chr7:3339400-3340200	Bivalent Enhancer	Fetal Thymus	thymus
10	chr7:3339400-3340600	Bivalent/Poised TSS	iPS-15b Cell Line	embryonic stem cell
11	chr7:3339400-3340600	Bivalent Enhancer	Placenta	Placenta
12	chr7:3339600-3340000	Enhancers	ES-WA7 Cell Line	embryonic stem cell
13	chr7:3339600-3340000	Enhancers	H9 Cell Line	embryonic stem cell
14	chr7:3339600-3340000	Flanking Bivalent TSS/Enh	HUES6 Cell Line	embryonic stem cell
15	chr7:3339600-3340000	Enhancers	Breast Myoepithelial Primary Cells	Breast
16	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper naive cells fromperipheralblood	blood
17	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper cells PMA-I stimulated	--
18	chr7:3339600-3340000	Bivalent Enhancer	Primary T helper 17 cells PMA-I stimulated	--
19	chr7:3339600-3340000	Bivalent Enhancer	Primary T killer memory cells from peripheral blood	blood
20	chr7:3339600-3340000	Bivalent Enhancer	Primary hematopoietic stem cells G-CSF-mobilized Female	--
21	chr7:3339600-3340000	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
22	chr7:3339600-3340000	Bivalent Enhancer	Adipose Nuclei	Adipose
23	chr7:3339600-3340000	Bivalent Enhancer	Fetal Intestine Small	intestine
24	chr7:3339600-3340000	Bivalent Enhancer	Stomach Smooth Muscle	stomach
25	chr7:3339600-3340000	Flanking Bivalent TSS/Enh	HepG2	liver
26	chr7:3339600-3340200	Bivalent Enhancer	Primary B cells from peripheral blood	blood
27	chr7:3339600-3340200	Bivalent Enhancer	Fetal Stomach	stomach
28	chr7:3339600-3340200	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
29	chr7:3339600-3342600	Bivalent/Poised TSS	HUES64 Cell Line	embryonic stem cell
30	chr7:3339800-3340000	Enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
31	chr7:3339800-3340000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
32	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
33	chr7:3339800-3340000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
34	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	HUES48 Cell Line	embryonic stem cell
35	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
36	chr7:3339800-3340000	Bivalent Enhancer	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	Primary neutrophils fromperipheralblood	blood
38	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	Primary hematopoietic stem cells short term culture	blood
39	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	Primary T helper naive cells from peripheral blood	blood
40	chr7:3339800-3340000	Bivalent Enhancer	Primary T helper cells fromperipheralblood	blood
41	chr7:3339800-3340000	Bivalent Enhancer	Primary T regulatory cells fromperipheralblood	blood
42	chr7:3339800-3340000	Bivalent Enhancer	Muscle Satellite Cultured Cells	--
43	chr7:3339800-3340000	Bivalent Enhancer	Cortex derived primary cultured neurospheres	brain
44	chr7:3339800-3340000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr7:3339800-3340000	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
46	chr7:3339800-3340000	Enhancers	Aorta	Aorta
47	chr7:3339800-3340000	Enhancers	Brain Anterior Caudate	brain
48	chr7:3339800-3340000	Flanking Bivalent TSS/Enh	Brain Hippocampus Middle	brain
49	chr7:3339800-3340000	Enhancers	Brain Inferior Temporal Lobe	brain
50	chr7:3339800-3340000	Bivalent Enhancer	Brain Dorsolateral Prefrontal Cortex	brain

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links